HFS
TEVA icon

Hantz Financial Services’s Teva Pharmaceuticals TEVA Stock Holding History

Hantz Financial Services’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.42M Buy
41,890
+5,629
+16% +$187K 0.02% 420
2026
Q1 		$1.09M Sell
36,261
-1,127
-3% -$36.3K 0.02% 470
2025
Q4 		$1.17M Buy
37,388
+15,620
+72% +$385K 0.02% 446
2025
Q3 		$440K Buy
21,768
+15,630
+255% +$275K 0.01% 576
2025
Q2 		$103K Buy
6,138
+5,715
+1,351% +$92.2K ﹤0.01% 761
2025
Q1 		$7K Buy
+423
New +$7.56K ﹤0.01% 1072

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Hantz Financial Services's TEVA Position: Q2 2026 in Review

Hantz Financial Services increased its Teva Pharmaceuticals (TEVA) stake by 16% in Q2 2026, buying an estimated $187K and bringing the position to 41,890 shares worth $1.42M. The position accounts for 0.02% of the portfolio, ranked #420.

Hantz Financial Services first reported a position in TEVA in Q1 2025 and has held it in 6 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Hantz Financial Services held 41,890 shares of Teva Pharmaceuticals worth $1.42M as of Q2 2026.
  • Hantz Financial Services bought 5,629 Teva Pharmaceuticals shares in Q2 2026, an estimated $187K.
  • Teva Pharmaceuticals made up 0.02% of Hantz Financial Services's portfolio in Q2 2026, its #420 holding.
  • Hantz Financial Services first reported a position in Teva Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.